Epinephrine provided a slight 30-day survival benefit, but those patients experienced more severe brain damage. Also today, nerve growth factor inhibitor shows phase-3 efficacy in osteoarthritis, National Academies issues a 5-step plan to address infections linked to opioid use disorder, and there may be beneficial class effects of SGLT2 inhibitors, including dapagliflozin.
Too few women oncology investigators; is a rigid HPV vaccination schedule needed?
SPECIAL: ASCO Journal Club with Blood & Cancer host David Henry, MD
Do cannabis laws cut opioid deaths? Plus, residents swamped by debt, job offers
Treat insomnia like a disorder; what's causing new psychiatric symptoms?
Some cognitive changes 'normal' with aging; obesity declined among lower-income children
Chronic opioids and ankylosing spondylitis; 2/3 of gyn-oncs experienced sexual harassment
Does aspirin prevent anything? And how to pick the right diabetes drug
Coffee, tea, and soda increase GERD risk
Government pleas for measles vaccination
ACP Internal Medicine Meeting 2019
AAD 2019 meeting wrap-up
HIV prevention progress slows
FDA weighs esketamine for depression
Time to switch to automated BP readings?
Special Report: SABCS
Ask if kids' parents are military
US life expectancy down
TENS cuts fibromyalgia pain
A change in ‘incident to’ billing
Benzodiazepines double risk of suicide for COPD patients
Create your
podcast in
minutes
It is Free
Good Mood Revolution
The Relaxback UK Show
On Call With Dr. Anselm Anyoha
Precision Medicine Forum Podcast
The Doctor’s Farmacy with Mark Hyman, M.D.
The Peter Attia Drive